SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-17-002419
Filing Date
2017-04-28
Accepted
2017-04-28 17:06:58
Documents
4
Period of Report
2017-06-19
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_042817.htm DEF 14A 254823
2 GRAPHIC simard.jpg GRAPHIC 29341
3 GRAPHIC proxy_01.jpg GRAPHIC 152399
4 GRAPHIC proxy_02.jpg GRAPHIC 78890
  Complete submission text file 0001171843-17-002419.txt   614644
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37347 | Film No.: 17796871
SIC: 2834 Pharmaceutical Preparations